- Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.
- Collaboration agreements for oncology candidates were signed between several major pharmaceutical companies.
- A partnership involving Recursion Pharmaceuticals, Sanofi, Roche, Merck, and Relay Therapeutics diversifies pipelines across oncology and immunology, leveraging AI-driven platforms.
Recursion Pharmaceuticals announced strategic alliances with Bayer, Sanofi, Roche, Merck, and Genentech.
4 reports, 3 independent
Updated Thu 00:00
No new developments lately
- Reports
- 4
- Developments
- 5
- Repetition
- 25%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Recursion Pharmaceuticals announced strategic alliances with Bayer, Sanofi, Roche, Merck, and Genentech.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Sanofi and Recursion Pharmaceuticals formed a partnership to develop AI-enabled therapies.Sub-event
Ark Invest commits $200M investment and collaboration with Sanofi.1 source
Recursion expands partnerships with Bayer and Roche, leveraging Nvidia's data processing capabilities.1 source
- A critical strategic collaboration has formed involving Hoffmann-La Roche, Recursion, Recordati, Moderna, Sanofi, and Merck KGaA to diversify pipelines through automated biological research.Sub-event
Recursion expands its strategic alliances to include Bayer, alongside existing partners Sanofi, Roche, and Merck.1 source
Keep exploring
The entities involved
-
Recursion (United States)
company in Salt Lake City, United States
Nothing else this week.
-
BAYER
company in Prague, Czechia
-
Sanofi
French pharmaceutical company